domingo, 8 de mayo de 2016

The challenge of consent in clinical genome-wide testing. - PubMed - NCBI

The challenge of consent in clinical genome-wide testing. - PubMed - NCBI



 2016 Apr 28. pii: archdischild-2013-304109. doi: 10.1136/archdischild-2013-304109. [Epub ahead of print]

The challenge of consent in clinical genome-wide testing.

Abstract

Genome-wide testing methods include array comparative genomic hybridisation (aCGH), multiple gene panels, whole exome sequencing (WE) and whole genome sequencing (WGS). Here we introduce some of the key ethical and social considerations relating to informed consent for the testing of children, particularly the management of incidental findings and variants of unknown significance.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/

KEYWORDS:

Ethics; General Paediatrics; Genetics; Neonatology

PMID:
 
27127186
 
[PubMed - as supplied by publisher]

No hay comentarios: